SAIMSARA Journal

Machine Generated Science • ISSN 3054-3991

AI Clinical Scribe Limitations: Scoping Review with ☸️SAIMSARA.

Digital Health icon

Digital Health

Issue 3, Volume 1, 2026

DOI: 10.62487/saimsara5a879885

Editorial note
• Last update: 2026-05-13 22:48:36
What is this paper about
AI clinical scribes can reduce documentation burden, but this evidence map shows why they are not yet safe as autonomous note-writers: hallucinations, omissions, acoustic failures, EHR friction, consent gaps, and medicolegal uncertainty remain central limitations. The full SAIMSARA evidence map gives a structured, reference-linked view of where ambient AI documentation works, where it fails, and what clinicians, vendors, and health systems must verify before scaling it.
Human-verified editorial review Verified by World ID proof-of-human. This editorial layer was submitted from a SAIMSARA account verified as a unique human.


Evidence preview · Did you know?
Realistic clinical room scene showing an AI scribe microphone placed too far from a doctor-patient conversation.

Room setup can make the note fail

Did you know? In simulated primary care recordings, a 4.5 m microphone distance produced 100% clinical fact omission, while placement within 2 m produced fewer than 5 omissions.

A clinical scribe can become unsafe before the model even starts: poor audio can erase the clinical story.

Realistic medical documentation screen showing an AI-generated SOAP note being checked for missing clinical facts.

The missing facts are the danger

Did you know? ChatGPT-4 SOAP notes averaged 23.6 errors per case, and 86% of those errors were omissions.

The risky output may not be a bizarre false sentence, but a missing history, decision, or operative detail.

Realistic hospital governance scene showing consent forms, data privacy controls, and ambient AI documentation oversight.

Consent practice is still uneven

Did you know? In one New Zealand provider study, only 59% reported seeking patient consent and 66% read terms and conditions.

This makes governance, not only accuracy, a core deployment risk for ambient clinical AI.

Swipe sideways on mobile · full evidence map opens after unlock
Abstract: To identify and synthesize the primary limitations, barriers to implementation, and risks associated with the use of AI clinical scribes in outpatient and inpatient medical settings. The review uses 43 references and builds its evidence map from 50 original studies with 25717 total participants/sample observations (topic-deduplicated ΣN). This scoping review suggests that the dominant limitation of AI clinical scribes is a persistent accuracy-oversight gap: ambient tools frequently produce hallucinations and omissions, with one comparison reporting hallucinations in 31% versus 20% of expert notes and ChatGPT-4 SOAP notes averaging 23.6 errors per case, 86% of which were omissions. These accuracy concerns are compounded by degraded performance in complex encounters, noisy environments, and multi-speaker conversations, alongside unresolved EHR integration, consent, and medicolegal barriers. The findings support a role for AI scribes as assistive rather than autonomous documentation tools, contingent on mandatory clinician verification and environmental optimization. Future research should prioritize standardized validation benchmarks and longitudinal evaluation of clinically significant errors across diverse specialties and acoustic settings to clarify where ambient AI documentation can be safely scaled.

Keywords: AI hallucinations; Data privacy; EHR integration; Clinical inaccuracies; Medicolegal liability; Informed consent; Acoustic interference; Documentation bias; Workflow integration; Fact omission

Review Stats

Get access to the full paper

Unlock the full evidence map

The full evidence review, including the Introduction, Methods, Results, Discussion, Conclusion, figures, and complete reference index, opens after purchase or sign-in. The Evidence Object JSON is a separate machine-readable evidence product: a concentrated synthesis of results, topic-level evidence, and discussion across original and non-original studies. It can be directly input into your LLM, agent, or RAG workflow.

Reference Index (43)